V.G.I Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 8 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 13.07 Cr
- Revenue Growth -8.39%
- Profit Growth 23.85%
- Ebitda 84.37%
- Net Worth -8.20%
- Total Assets -13.83%
About V.G.I Pharma
V.G.I Pharma Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 June 2011 and has a history of 13 years and eight months. Its registered office is in Akola, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹13.07 Cr.
Rohit Bajaj and Naresh Bajaj serve as directors at the Company.
Company Details
-
Location
Akola, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24200MH2011PTC218263
-
Company No.
218263
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Jun 2011
-
Date of AGM
30 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at V.G.I Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Bajaj
|
Director | 03-Jun-2011 | Current |
|
Naresh Bajaj
|
Director | 03-Jun-2011 | Current |
Financial Performance of V.G.I Pharma.
V.G.I Pharma Private Limited, for the financial year ended 2019, experienced Minor drop in revenue, with a 8.39% decrease. The company also saw a substantial improvement in profitability, with a 23.85% increase in profit. The company's net worth dipped by a decrease of 8.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of V.G.I Pharma?
In 2019, V.G.I Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Healthledger Private LimitedRohit Bajaj is a mutual person
-
Healthledger Diagnostics Private Limited
Rohit Bajaj is a mutual person
-
Nb-4 Energy Solutions Private LimitedRohit Bajaj is a mutual person
-
Smartqr Technologies Private Limited
Rohit Bajaj is a mutual person
-
Qraft Diagnostics Private Limited
Rohit Bajaj is a mutual person
Charges (Loans)
₹130.74 M
₹0
Charges Breakdown by Lending Institutions
- Others : 13.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2014 | Others | ₹2.82 Cr | Open |
| 26 Oct 2011 | Others | ₹1.75 Cr | Open |
| 26 Oct 2011 | Others | ₹5.50 Cr | Open |
| 13 Oct 2011 | Others | ₹3.00 Cr | Open |
How Many Employees Work at V.G.I Pharma?
V.G.I Pharma has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of V.G.I Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped V.G.I Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
